Mohamed Zoelfigar, Vankudre Gopi Suesh, Ayyappan Janitha Plackal, Noushad Babu, Alzeedi Awatif Nasser, Alazzani Sheikha Said, Alkaabi Aisha Juma
Department of Optometry, College of Health Sciences, University of Buraimi, Al Buraimi, Sultanate of Oman.
Ophthalmology Department, Al Buraimi Hospital, Al Buraimi, Sultanate of Oman.
Clin Optom (Auckl). 2024 May 19;16:123-129. doi: 10.2147/OPTO.S462498. eCollection 2024.
The global prevalence of diabetic retinopathy (DR) among individuals with diabetes is 22.27%. This highlights the likelihood of developing burden of retinopathy within the at risk population and can have a detrimental impact on an individual's quality of life (QoL). The aim of this study is to assess the vision-related QoL in individuals with (DR) in a hospital-based population in the Al-Buraimi governorate, Sultanate of Oman.
The study was conducted in the Ophthalmology Outpatient Department of Al Buraimi Hospital and Polyclinic. This study enrolled 218 patients (114 males, 104 females) diagnosed with DR. The NEI-VFQ-25 questionnaire was adopted in this study. The patients were classified into different groups according to their type of diabetes and other relevant demographic information.
A total of 218 patients responded to the NEI-VFQ-25 questionnaire. The mean age of the participants was 57.49 ± 12.3 years, 52.3% were male, and 47.7% were female. The overall QoL score was 41.53± 20.8. Patients aged more than 75 years had the lowest QoL scores compared with the other age groups (). The results showed that the duration of diabetes had no significant impact on the overall QoL scores (). A higher QoL score was observed among patients with type II diabetes mellitus (DM) than with type I diabetes mellitus (). Patients diagnosed with proliferative DR (PDR) had a significantly lower QoL score than those diagnosed at other stages ().
The QoL of the population with DR is negatively affected by various factors, including demographics, disease severity, and in patients with DM type II. It is important to consider these factors to enhance QoL in patients with DR. Regular evaluation of an individual's QoL is beneficial for both physicians and healthcare teams.
糖尿病患者中糖尿病视网膜病变(DR)的全球患病率为22.27%。这凸显了高危人群中发生视网膜病变负担的可能性,并且可能对个体的生活质量(QoL)产生不利影响。本研究的目的是评估阿曼苏丹国布赖米省一家医院中患有DR的个体的视力相关生活质量。
本研究在布赖米医院及综合诊所的眼科门诊进行。本研究纳入了218例被诊断为DR的患者(114例男性,104例女性)。本研究采用了NEI-VFQ-25问卷。根据患者的糖尿病类型及其他相关人口统计学信息将其分为不同组。
共有218例患者对NEI-VFQ-25问卷做出了回应。参与者的平均年龄为57.49±12.3岁,52.3%为男性,47.7%为女性。总体生活质量得分为41.53±20.8。与其他年龄组相比,75岁以上的患者生活质量得分最低。结果显示糖尿病病程对总体生活质量得分无显著影响。II型糖尿病(DM)患者的生活质量得分高于I型糖尿病患者。被诊断为增殖性DR(PDR)的患者的生活质量得分显著低于在其他阶段被诊断的患者。
DR人群的生活质量受到多种因素的负面影响,包括人口统计学因素、疾病严重程度以及II型糖尿病患者。考虑这些因素对于提高DR患者的生活质量很重要。定期评估个体的生活质量对医生和医疗团队都有益。